RIVERCELL
LIVE

Serial Number

99599095

Owner

Blossom Life Sciences SAS

Attorney

Ryan Van Olst

Filing Date

Jan 16, 2026

Add to watchlist:

No watchlists yet
View on USPTO

RIVERCELL Trademark

Serial Number: 99599095

RIVERCELL is a trademark filed by Blossom Life Sciences SAS on January 16, 2026. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services). The application is currently pending registration.

Owner Contact Info

Blossom Life Sciences SAS (2 trademarks)

23 rue du Départ (Boite 37)

Entity Type: 98

Trademark Details

Filing Date

January 16, 2026

Registration Date

Not Registered

Published for Opposition

June 16, 2026

Goods & Services

Licensing of intellectual property rights in the fields of cell biology, biotechnology, and drug discovery

Downloadable and recorded software for predicting cellular behavior by collecting, analyzing, and organizing data, analyzing cell behavior and physiology, and modeling biological responses, and supporting drug discovery research and innovation by collecting, analyzing, and organizing data, generating insights about cell states and cell responses to perturbations, and evaluating drug candidates; downloadable and recorded computer software using artificial intelligence (AI) for predicting cellular behavior by collecting, analyzing, and organizing data, using machine learning on images and sequencing output, and modeling biological responses, and supporting drug discovery research and innovation by collecting, analyzing, and organizing data, generating insights about cell states and cell responses to perturbations, and evaluating drug candidates; downloadable and recorded software for generating data in the fields of cell biology, biotechnology, and drug discovery; downloadable and recorded computer software using artificial intelligence (AI) for generating data in the fields of cell biology, biotechnology, and drug discovery; laboratory equipment, namely, liquid handlers in the nature of laboratory robots, microscopes and incubators

Scientific research and development services in the fields of cell biology, biotechnology, and drug discovery; conducting scientific research in the fields of cell biology, biotechnology, and drug discovery; conducting cell perturbation experiments for scientific research and drug discovery purposes, namely, scientific research and drug discovery services; data generation, curation, and analysis in the nature of scientific research services in the fields of cell biology, biotechnology, and drug discovery; providing temporary use of non-downloadable cloud-based software for predicting cellular behavior by collecting, analyzing, and organizing data, analyzing cell behavior and physiology, and modeling biological responses, and supporting drug discovery research and innovation by collecting, analyzing, and organizing data, generating insights about cell states and cell responses to perturbations, and evaluating drug candidates; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for predicting cellular behavior by collecting, analyzing, and organizing data, using machine learning on images and sequencing output, and modeling biological responses, and supporting drug discovery research and innovation by collecting, analyzing, and organizing data, generating insights about cell states and cell responses to perturbations, and evaluating drug candidates; providing temporary use of non-downloadable cloud-based software for generating data in the fields of cell biology, biotechnology, and drug discovery; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for generating data in the fields of cell biology, biotechnology, and drug discovery

Filing History

APPROVED FOR PUB - PRINCIPAL REGISTER
May 20, 2026 CNSA
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 20, 2026 GNEN
EXAMINER'S AMENDMENT ENTERED
May 20, 2026 XAEC
EXAMINERS AMENDMENT E-MAILED
May 20, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 20, 2026 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 19, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 19, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 19, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 14, 2026 GNRN
NON-FINAL ACTION E-MAILED
May 14, 2026 GNRT
NON-FINAL ACTION WRITTEN
May 14, 2026 CNRT
ASSIGNED TO EXAMINER
May 14, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 21, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Jan 16, 2026 MAFR
NEW APPLICATION ENTERED
Jan 16, 2026 NWAP